Clinical Trial Update: Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluated erlotinib in combination with chemotherapy for metastatic colorectal cancer; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED